DJIA 17,757.91 0.00 0.00%
NASDAQ 5,013.12 0.00 0.00%
S&P 500 2,077.42 0.00 0.00%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Insiders Are Buying Up Opko Health, Here's Why

Wednesday's Mid-Day Movers: Chubb, Rock Creed, RADA Win; Peabody Energy, Ballard Fall

Top Takeaways From BMO's Specialty Pharma Day

Health Care Sector Update for 07/01/2015: TEVA, XENE, KITE, RCPI

Unusual Covered Call Opportunity Teva Pharmaceuticals

The Biotech Drug Lord: How One Man Is Conquering The Biotech Space

Phillip Frost's Opko Health shares are soaring, but The Fool's Michael Douglass and Todd Campbell worry that valuation has become a bit stretched. Here's why.

Short Sellers Become More Focused on Big Pharma

Concert Gets $50 Million From Auspex; Remains An Attractive Opportunity

Is Teva Pharmaceutical's Day of Reckoning Upon It?

A court decision invalidating a key patent clears the way for Novartis and Momenta to launch their Copaxone biosimilar.

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog
See More Articles...